Article
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristics.
Cytometry. Part B, Clinical cytometry - 1 Mar 2021
Panda Devasis, Chatterjee Gaurav, Sardana Rohan, Khanka Twinkle, Ghogale Sitaram, Deshpande Nilesh, Badrinath Yajamanam, Shetty Dhanalaxmi, Narula Gaurav, Banavali Shripad, Patkar Nikhil V, Gujral Sumeet, Subramanian Papagudi G, Tembhare Prashant R
Abstract excerpt
INTRODUCTION: In 2016, Children Oncology Group (COG) described a new high-risk subtype of acute myeloid leukemia (AML) with a distinct immunophenotypic-signature, RAM-phenotype (RAM-AML). Data on clinical and laboratory features of RAM-AML are still limited to COG report only. Herein, we report the clinicopathological characteristics and detailed immunophenotypic features of RAM-AML patients. In COG report, 38%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
